OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
JBIO holding history
Jade Biosciences, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JBIO overviewAll 13F holders of JBIOFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −185,011−100.0% | Sold out | Holders |
| Q1 2026 | 185,011 | $2.60M | 0.1% | −346,152−65.2% | Reduced | Holders |
| Q4 2025 | 531,163 | $8.20M | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 531,163 | $4.58M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 531,163 | $5.31M | 0.1% | +531,163 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −565,374−100.0% | Sold out | Holders |
| Q1 2024 | 565,374 | $16.7M | 0.3% | −191,556−25.3% | Reduced | Holders |
| Q4 2023 | 756,930 | $17.1M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 756,930 | $10.3M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 756,930 | $13.0M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2023 | 756,930 | $15.3M | 0.3% | −2,610−0.3% | Reduced | Holders |
| Q4 2022 | 759,540 | $22.3M | 0.4% | −35,460−4.5% | Reduced | Holders |
| Q3 2022 | 795,000 | $13.2M | 0.3% | +316,421+66.1% | Added | Holders |
| Q2 2022 | 478,579 | $7.48M | 0.1% | −31,370−6.2% | Reduced | Holders |
| Q1 2022 | 509,949 | $9.35M | 0.2% | −25,765−4.8% | Reduced | Holders |
| Q4 2021 | 535,714 | $6.32M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 535,714 | $11.2M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 535,714 | $12.2M | 0.1% | +535,714 | New | Holders |